• Sign In to gain access to subscriptions and/or My Tools.
Impact Factor:1.627 | Ranking:Geriatrics & Gerontology 35 out of 50 | Clinical Neurology 136 out of 192
Source:2014 Journal Citation Reports® (Thomson Reuters, 2015)

Review: Caffeine: Neuroprotective Functions in Cognition and Alzheimer's Disease

  1. Andi Rosso, MPH
    1. Department of Neurology Drexel University College of Medicine, alr44{at}drexel.edu, Department of Epidemiology and Biostatistics Drexel University School of Public Health, Philadelphia, Pennsylvania
  1. Jana Mossey, PhD
    1. Department of Epidemiology and Biostatistics Drexel University School of Public Health, Philadelphia, Pennsylvania
  1. Carol F. Lippa, MD
    1. Department of Neurology Drexel University College of Medicine

Abstract

Alzheimer's disease is a common problem in our elderly population. Although research is leading to improvements in our understanding of the underlying biology, we still have little understanding of the environmental risk factors associated with this disorder. Caffeine, an easily modifiable environmental factor, may have a protective effect on the likelihood of developing Alzheimer's disease. This article reviews the association between caffeine from both a biologic and epidemiologic perspective. Further studies are needed to determine whether caffeine consumption could have a major affect on the development of Alzheimer's disease or age-related cognitive decline.

| Table of Contents

This Article

  1. AM J ALZHEIMERS DIS OTHER DEMEN vol. 23 no. 5 417-422
    All Versions of this Article:
    1. current version image indicatorVersion of Record - Oct 27, 2008
    2. 1533317508320083v2 - Jul 3, 2008
    3. 1533317508320083v1 - Jun 30, 2008
    What's this?
  1. References

Share